Drug pricing legislation and Washington’s health care agenda
Health care in the United States has always been controversial, and issues like PBMs, Medicaid, site-neutral payments and the high cost of drugs like insulin are coming to a head. In this report, Axios Pro analyzes key drug pricing and health care legislation to watch this year.
Get the report
To download this free report, please complete the form below:
Table of contents
- 1. Introduction
- 2. Overview
- 3. Congressional outlook
- 4. What’s next
Why it matters
With decades of combined experience, deep industry connections, and dozens of exclusive stories broken this year, nobody knows policy better than the Axios Pro newsroom.
What's inside:
The current state of drug pricing legislation and battle lines
Congress’ outlook on health care this year
How Republicans and Democrats are positioned
The outside influences and externalities that matter
Forecasting on new technologies to watch
